Skip to main content

Author: Eric Schatzkin


Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria’s private sector

The subcutaneous depot medroxyprogesterone acetate (DMPA-SC) injectable contraceptive was introduced in South West Nigeria in 2015 through private sector channels. The introduction included community-based distribution and was supported by a social marketing approach. From program monitoring and evaluation, aimed at understanding performance, market reach and other process measures, we identify lessons learned to inform future scale-up efforts. We synthesized the findings from a core set of key performance indicators collected through different methods: (1) implementer performance indicators, (2) phone survey of DMPA-SC users (n=541) with a follow-up after 3 months (n=342) and (3) in-depth interviews with 57 providers and 42 users of DMPA-SC

Institutional author(s): University of California San Francisco, Akena Associates, DKT Nigeria, American University of Beirut
Individual author(s): Jenny Liu, Eric Schatzkin, Elizabeth Omoluabi, Morenike Fajemisin, Chidinma Onuoha, Temitope Erinfolami, Kazeem Ayodeji, Saliu Ogunmola, Jennifer Shen, Nadia Diamond-Smith, Maia Sieverding
Publication date: July, 2018

Journal article Link to Journal Article